Fig. 6.
A, Relative body weight from Vip+/+ and Vip−/− male (n = 4–5 per group) and female mice (n = 6–7 per group) given dextran sodium sulfate (2.5% for males and 3.0% for females) in the drinking water for 10 d and administered GLP-2 (0.2 mg/kg) or vehicle once (female) or twice (male) daily. Two-way ANOVA indicated that the weight loss curves from vehicle-treated Vip+/+ and Vip−/− female mice were significantly different (P < 0.001). B, Disease activity index in Vip+/+ and Vip−/− male and female mice after 10 d of oral DS and vehicle or GLP-2 treatment. *, P < 0.05; **, P < 0.01, GLP-2- and vehicle-treated, respectively, Vip−/− vs. vehicle-treated Vip+/+.